Advanced pharmacy service provision in community pharmacy across the United Kingdom and Ireland: A Scoping review

IF 3.7 3区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH
Muireann Counihan , Isabella Stein , Cecilia Flynn , Aishling O'Regan , Shane Clarke , Mark Ledwidge , Cristín Ryan
{"title":"Advanced pharmacy service provision in community pharmacy across the United Kingdom and Ireland: A Scoping review","authors":"Muireann Counihan ,&nbsp;Isabella Stein ,&nbsp;Cecilia Flynn ,&nbsp;Aishling O'Regan ,&nbsp;Shane Clarke ,&nbsp;Mark Ledwidge ,&nbsp;Cristín Ryan","doi":"10.1016/j.sapharm.2025.01.011","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>The scope of practice for community pharmacists across the United Kingdom (UK) and Ireland is expanding, with advanced pharmacy services (APS) that exceed the traditional scope of practice of a community pharmacist being provided. Current literature highlights that there is variation in APS provision and renumeration for those service across the UK and Ireland.</div></div><div><h3>Aim</h3><div>This scoping review aims to describe and compare the APS provided by community pharmacists across the UK and Ireland for which community pharmacists receive government reimbursement and explore stakeholder perspectives of these services.</div></div><div><h3>Method</h3><div>This scoping review was reported according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews Checklist and followed Arskey and O'Malley's guidance for undertaking scoping reviews. Systematic searches of the electronic databases Embase, PubMed, SCOPUS and Google Scholar were undertaken using search terms such as ‘community pharmacist’ and ‘advanced service’, from January 2010 to August 2022. Articles were included if they reported an APS, renumeration for an APS and/or stakeholders' views of APS. Results were summarised narratively.</div></div><div><h3>Results</h3><div>After screening 4009 records, 75 publications were included. More Government renumerated APS were provided across the UK [Wales (n = 14); England (n = 10); Scotland (n = 8); Northern Ireland (n = 4)] than in Ireland (n = 4). Stakeholders (patients, pharmacists and general practitioners) found the provision of APS in community pharmacy ideal especially when tailored to local demographic needs, noting accessibility and economic benefits as key advantages.</div></div><div><h3>Conclusion</h3><div>Despite similarities in the traditional services provided by community pharmacists, there is diversion in the provision and availability of APS across the UK and Ireland. Further APS could be provided in some countries which can reflect local population needs.</div></div>","PeriodicalId":48126,"journal":{"name":"Research in Social & Administrative Pharmacy","volume":"21 5","pages":"Pages 287-320"},"PeriodicalIF":3.7000,"publicationDate":"2025-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Research in Social & Administrative Pharmacy","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1551741125000117","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 0

Abstract

Background

The scope of practice for community pharmacists across the United Kingdom (UK) and Ireland is expanding, with advanced pharmacy services (APS) that exceed the traditional scope of practice of a community pharmacist being provided. Current literature highlights that there is variation in APS provision and renumeration for those service across the UK and Ireland.

Aim

This scoping review aims to describe and compare the APS provided by community pharmacists across the UK and Ireland for which community pharmacists receive government reimbursement and explore stakeholder perspectives of these services.

Method

This scoping review was reported according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews Checklist and followed Arskey and O'Malley's guidance for undertaking scoping reviews. Systematic searches of the electronic databases Embase, PubMed, SCOPUS and Google Scholar were undertaken using search terms such as ‘community pharmacist’ and ‘advanced service’, from January 2010 to August 2022. Articles were included if they reported an APS, renumeration for an APS and/or stakeholders' views of APS. Results were summarised narratively.

Results

After screening 4009 records, 75 publications were included. More Government renumerated APS were provided across the UK [Wales (n = 14); England (n = 10); Scotland (n = 8); Northern Ireland (n = 4)] than in Ireland (n = 4). Stakeholders (patients, pharmacists and general practitioners) found the provision of APS in community pharmacy ideal especially when tailored to local demographic needs, noting accessibility and economic benefits as key advantages.

Conclusion

Despite similarities in the traditional services provided by community pharmacists, there is diversion in the provision and availability of APS across the UK and Ireland. Further APS could be provided in some countries which can reflect local population needs.
在英国和爱尔兰的社区药房提供先进的药房服务:范围审查。
背景:实践的范围为社区药剂师在整个英国(英国)和爱尔兰正在扩大,先进的药房服务(APS),超过传统的实践范围的社区药剂师正在提供。目前的文献强调,有变化的APS提供和报酬为这些服务在英国和爱尔兰。目的:这一范围审查的目的是描述和比较的APS由社区药剂师在英国和爱尔兰提供的社区药剂师接受政府报销,并探讨这些服务的利益相关者的观点。方法:根据系统评价和荟萃分析扩展范围评价清单的首选报告项目进行范围评价报告,并遵循Arskey和O'Malley的范围评价指南。从2010年1月到2022年8月,使用“社区药剂师”和“先进服务”等搜索词对电子数据库Embase、PubMed、SCOPUS和谷歌Scholar进行了系统搜索。如果文章报道了APS, APS的薪酬和/或利益相关者对APS的看法,则将其纳入。对结果进行叙述总结。结果:筛选4009篇文献,纳入75篇文献。在英国各地提供了更多政府资助的APS[威尔士(n = 14);英国(n = 10);苏格兰(n = 8);北爱尔兰(n = 4)比爱尔兰(n = 4)。利益相关者(患者、药剂师和全科医生)发现,在社区药房提供APS是理想的,特别是在根据当地人口需求量身定制时,并指出可及性和经济效益是关键优势。结论:尽管社区药剂师提供的传统服务有相似之处,但在英国和爱尔兰的APS提供和可用性方面存在转移。在一些国家可以进一步提供可反映当地人口需要的APS。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Research in Social & Administrative Pharmacy
Research in Social & Administrative Pharmacy PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH-
CiteScore
7.20
自引率
10.30%
发文量
225
审稿时长
47 days
期刊介绍: Research in Social and Administrative Pharmacy (RSAP) is a quarterly publication featuring original scientific reports and comprehensive review articles in the social and administrative pharmaceutical sciences. Topics of interest include outcomes evaluation of products, programs, or services; pharmacoepidemiology; medication adherence; direct-to-consumer advertising of prescription medications; disease state management; health systems reform; drug marketing; medication distribution systems such as e-prescribing; web-based pharmaceutical/medical services; drug commerce and re-importation; and health professions workforce issues.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信